Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

bioMerieux, Pierre Fabre to go their separate ways?

This article was originally published in Clinica

Executive Summary

Only a year after joining together to form the largest French independent pharmaceutical/healthcare group, in vitro diagnostic manufacturer bioMerieux and pharmaceutical and skin cosmetics producer Pierre Fabre may decide to demerge. A spokesperson for the company in Paris said that the company was at the beginning of a "period of reflection that will last months rather than weeks" at the end of which a decision would be made. The companies merged on January 1 2001, at which point it was agreed to review the synergies and success of the merger after a year. Combined sales of $550 million (+0.5%) were recorded by the group in 2000.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT064549

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel